Последние добавленные видео:
ibrutinib
-
2 года назад
1376 2 года назад 1:05Long-term outcomes of patients with CLL treated with continuous ibrutinib
-
10 лет назад
12690 10 лет назад 11:28Adverse Events of Ibrutinib in Chronic Lymphocytic Leukemia
-
7 лет назад
265 7 лет назад 2:33About Targeted Cancer Treatment Imbruvica ( Ibrutinib )
-
9 лет назад
1825 9 лет назад 3:46The characteristics and mode of action of ibrutinib for CLL
-
8 лет назад
580 8 лет назад 4:00Jennifer R. Brown, MD, PhD: Ibrutinib and Atrial Fibrillation Risk in RCTs
-
8 лет назад
889 8 лет назад 5:20Treatment-associated atrial fibrillation: ibrutinib-specific or class-specific?
-
2 года назад
240 2 года назад 1:53Acalabrutinib vs ibrutinib in R/R CLL: assessing the burden of adverse events
-
2 дня назад
30 2 дня назад 2:31MAIC of ibrutinib versus other covalent BTK inhibitors in frontline CLL treatment
-
6 лет назад
516 6 лет назад 2:17CLL - Ibrutinib
-
6 лет назад
4924 6 лет назад 1:42Deciphering Ibrutinib Resistance in Chronic Lymphocytic Leukemia
-
2 года назад
86 2 года назад 1:27Managing cardiotoxicity associated with the use of ibrutinib
-
6 лет назад
165 6 лет назад 1:26Resonate: Ibrutinib associated with favourable PFS and OS in CLL
-
11 лет назад
1641 11 лет назад 2:05Dr. Tendler on the Mechanism of Action of Ibrutinib
-
7 лет назад
1406 7 лет назад 1:56Ibrutinib treatment and its associated risk factors
-
6 лет назад
Dr. Brander on the Safety and Efficacy of Ibrutinib/Venetoclax in CLL
Introduction ...
566 6 лет назад 2:12 -
6 лет назад
929 6 лет назад 3:22Treatment Strategies With Ibrutinib in CLL
-
1 год назад
1114 1 год назад 6:23#ibrutinib | Uses, Dosage, Side Effects & Mechanism | Imbruvica
-
2 года назад
294 2 года назад 2:06The role of ibrutinib in the frontline treatment of young patients with CLL
-
11 лет назад
2376 11 лет назад 1:17Dr. Woyach on BTK Inhibition and the Mechanism of Action of Ibrutinib